Personalized microbiome-based approaches to metabolic syndrome management and prevention (Q36175953)

12 August 2017

1 reference

title

Personalized microbiome-based approaches to metabolic syndrome management and prevention (English)

1 reference

12 August 2017

0 references

1 reference

3

Eran Elinav

1 reference

12 August 2017

1

Hagit Shapiro

1 reference

12 August 2017

Jotham Suez

2

1 reference

12 August 2017

27 October 2016

1 reference

12 August 2017

1 reference

12 August 2017

9

1 reference

12 August 2017

3

1 reference

12 August 2017

226-236

1 reference

Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation

12 August 2017

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12501

Long-term weight loss after diet and exercise: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12501

Persistent metabolic adaptation 6 years after "The Biggest Loser" competition

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12501

Randomised placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients. European Multicentre Orlistat Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12501

Evidence-based nutrition principles and recommendations for the treatment and prevention of diabetes and related complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12501

Implications of postprandial glucose and weight control in people with type 2 diabetes: understanding and implementing the International Diabetes Federation guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12501

(4) Foundations of care: education, nutrition, physical activity, smoking cessation, psychosocial care, and immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12501

Dietary carbohydrate (amount and type) in the prevention and management of diabetes: a statement by the american diabetes association

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12501

Interindividual variability and intra-individual reproducibility of glycemic index values for commercial white bread

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12501

Variability of the glycemic response to single food products in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12501

Personalized Nutrition by Prediction of Glycemic Responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12501

Structure, function and diversity of the healthy human microbiome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12501

Linking long-term dietary patterns with gut microbial enterotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12501

Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12501

Diet drives convergence in gut microbiome functions across mammalian phylogeny and within humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12501

Human genetics shape the gut microbiome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12501

Microbiome-wide association studies link dynamic microbial consortia to disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12501

Diet-microbiota interactions as moderators of human metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12501

The gut microbiota as an environmental factor that regulates fat storage

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12501

Microbial ecology: human gut microbes associated with obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12501

An obesity-associated gut microbiome with increased capacity for energy harvest

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12501

A metagenome-wide association study of gut microbiota in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12501

The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12501

Characterization of gut microbiomes in nonalcoholic steatohepatitis (NASH) patients: a connection between endogenous alcohol and NASH.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12501

Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12501

Gut Microbial Metabolite TMAO Enhances Platelet Hyperreactivity and Thrombosis Risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12501

Taking it Personally: Personalized Utilization of the Human Microbiome in Health and Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12501

Dietary Fiber-Induced Improvement in Glucose Metabolism Is Associated with Increased Abundance of Prevotella

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12501

Splenda alters gut microflora and increases intestinal p-glycoprotein and cytochrome p-450 in male rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12501

Low-dose aspartame consumption differentially affects gut microbiota-host metabolic interactions in the diet-induced obese rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12501

Dietary intervention impact on gut microbial gene richness

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12501

Growth dynamics of gut microbiota in health and disease inferred from single metagenomic samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12501

Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12501

Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12501

The cross talk between microbiota and the immune system: metabolites take center stage

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12501

Gut microbiota, metabolites and host immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12501

Quantifying Diet-Induced Metabolic Changes of the Human Gut Microbiome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12501

Microbial degradation of whole-grain complex carbohydrates and impact on short-chain fatty acids and health

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12501

Microbiota-generated metabolites promote metabolic benefits via gut-brain neural circuits

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12501

The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12501

Biological significance of short-chain fatty acid metabolism by the intestinal microbiome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12501

Microbiota and SCFA in lean and overweight healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12501

Butyrate improves insulin sensitivity and increases energy expenditure in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12501

Acetate mediates a microbiome-brain-β-cell axis to promote metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12501

Butyrate and propionate protect against diet-induced obesity and regulate gut hormones via free fatty acid receptor 3-independent mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12501

The microbiome and butyrate regulate energy metabolism and autophagy in the mammalian colon

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12501

Microbial modulation of energy availability in the colon regulates intestinal transit

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12501

Effects of targeted delivery of propionate to the human colon on appetite regulation, body weight maintenance and adiposity in overweight adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12501

Acute effects of intravenous and rectal acetate on glucagon-like peptide-1, peptide YY, ghrelin, adiponectin and tumour necrosis factor-alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12501

From Dietary Fiber to Host Physiology: Short-Chain Fatty Acids as Key Bacterial Metabolites

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12501

Effects of the gut microbiota on host adiposity are modulated by the short-chain fatty-acid binding G protein-coupled receptor, Gpr41

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12501

The gut microbiota suppresses insulin-mediated fat accumulation via the short-chain fatty acid receptor GPR43.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12501

Bile acids: regulation of synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12501

Pleiotropic roles of bile acids in metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12501

The enzymes, regulation, and genetics of bile acid synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12501

Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12501

Systemic gut microbial modulation of bile acid metabolism in host tissue compartments

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12501

TGR5-mediated bile acid sensing controls glucose homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12501

Targeting bile-acid signalling for metabolic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12501

Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12501

FXR, a multipurpose nuclear receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12501

Gut microbiota from twins discordant for obesity modulate metabolism in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12501

Microbiota-induced obesity requires farnesoid X receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12501

Intestinal farnesoid X receptor signaling promotes nonalcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12501

Intestinal FXR agonism promotes adipose tissue browning and reduces obesity and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12501

FXR is a molecular target for the effects of vertical sleeve gastrectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12501

Immune regulation of metabolic homeostasis in health and disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12501

Metabolic endotoxemia initiates obesity and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12501

Lipopolysaccharide activates an innate immune system response in human adipose tissue in obesity and type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12501

Modulation of gut microbiota by antibiotics improves insulin signalling in high-fat fed mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12501

Gut-derived lipopolysaccharide augments adipose macrophage accumulation but is not essential for impaired glucose or insulin tolerance in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12501

Crosstalk between Gut Microbiota and Dietary Lipids Aggravates WAT Inflammation through TLR Signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12501

Microbiota-Modulated Metabolites Shape the Intestinal Microenvironment by Regulating NLRP6 Inflammasome Signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12501

Xenobiotics shape the physiology and gene expression of the active human gut microbiome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12501

Transkingdom control of microbiota diurnal oscillations promotes metabolic homeostasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12501

Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12501

Gut metagenome in European women with normal, impaired and diabetic glucose control

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12501

Diet rapidly and reproducibly alters the human gut microbiome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12501

The effect of diet on the human gut microbiome: a metagenomic analysis in humanized gnotobiotic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12501

A core gut microbiome in obese and lean twins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12501

Richness of human gut microbiome correlates with metabolic markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12501

Personalized nutrition through big data.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12501

Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12501

Oral probiotic administration induces interleukin-10 production and prevents spontaneous autoimmune diabetes in the non-obese diabetic mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12501

Probiotics lower plasma glucose in the high-fat fed C57BL/6J mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12501

Effect of Probiotics on Glycemic Control: A Systematic Review and Meta-Analysis of Randomized, Controlled Trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12501

Probiotics and obesity: a link?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12501

Enterobacteria-mediated deconjugation of taurocholic acid enhances ileal farnesoid X receptor signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12501

21 January 2018

Identifiers

DOI

10.1111/1753-0407.12501

1 reference

12 August 2017

1 reference

PubMed ID

27787945